Russell James Hubbard Ryan

Massachusetts General Hospital

$3,033,509

Attributed

$3,033,509

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $500.7K · FY2016–25

$1M$750K$500K$250K$0

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,033,509 · 3

By mechanism

R01$2,242,679 · 2

K08$790,830 · 1

Top collaborators

No co-investigators on record.

Most similar at Massachusetts General Hospital

Same institution · by research overlap

Katia Georgopoulos$27,357,145
Schahram Akbarian$48,610,378
David T Scadden$62,181,067
Pamela Sklar$31,628,187
Marcela Valderrama Maus$16,508,365

Others in their field

Top investigators on “Enhancers”

Margaret Juliana McElrath · Fred Hutchinson Cancer Center$383,951,488
Mitchell J Malone · Texas A&M Research Foundation$344,583,004
Gary D Acton · University Of California-Davis$320,373,312
Lawrence Corey · Fred Hutchinson Cancer Center$313,017,695
Chanza Baytop · Westat, Inc.$271,217,917
Everette D Joseph · Howard University$249,567,890

Research focus

EnhancersInvestigationTranscription FactorPathway InteractionsDistalMutationHigh RiskRefractory DiseaseBiologyXenograft ProcedureCell LineElementsB-Cell LymphomasComplexAcetylationIn VitroNotch ProteinNovel Therapeutic InterventionMediatingMantle Cell LymphomaLymphomaGene MutationRecurrenceGene Activation